Target intelligence / Profile preview

novel transcript, antisense to CHURC1 (ENSG00000303859 (no widely used abbreviation beyond this locus ID))

Target
ENSG00000303859 (no widely used abbreviation beyond this locus ID)
Molecular classification
Other (long non-coding RNA, lncRNA; not a protein-coding gene or regulatory element with established function)
01

Overview

The gene \"novel transcript, antisense to CHURC1\" (ENSG00000303859, LOC105370534) is annotated as a long non-coding RNA gene predicted to occur antisense to the protein-coding gene CHURC1 on chromosome 14. Available public resources only indicate that this is a lncRNA locus and the nearest protein-coding gene is SPTB, located over 10kb away. There is no functional, disease, or pharmacological information, and the transcript is not recognized as a protein, receptor, enzyme, or transporter. No evidence supports this as a validated therapeutic target, and its biological significance remains undetermined in peer-reviewed resources[5][7]. This locus is not the well-annotated CHURC1 gene (sometimes called Churchill domain containing 1), which is a protein-coding gene involved in neural development and cell movement regulation[3]. ENSG00000303859 is instead a non-coding transcript with no established molecular or pathological function.

Other names
LOC105370534ENSG00000303859novel transcript antisense to CHURC1

Beyond the preview

Go deeper on novel transcript, antisense to CHURC1 (ENSG00000303859 (no widely used abbreviation beyond this locus ID)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on novel transcript, antisense to CHURC1 (ENSG00000303859 (no widely used abbreviation beyond this locus ID)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call